Skip to content

Cash ratio at other companies

Amgen logo
AmgenAMGN
0.0×
Moderna logo
ModernaMRNA
0.8×-0.2×
Royalty Pharma logo
Royalty PharmaRPRX
1.1×+0.2×
ALN
Alnylam PharmaceuticalsALNY
1.3×+0.3×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.3×-0.1×
Incyte logo
IncyteINCY
2.3×+1.2×

Other financials

Income statement

See full
Revenue$2.5M-66.7%

Balance sheet

See full
Cash & equivalents$1.4B+1,411%
Total debt$107.4M+7.3%
Total equity$4.5B-3.4%
Total assets$5.7B+5.0%

Cash flow

See full
Operating cash flow-$163.8M+5.1%
CapEx$1.3M+55.5%
Free cash flow-$165.1M+4.8%

Valuation

See full
Market cap$22.61B+175%
Enterprise value$21.29B+157%
P/S2,736.9×+2,454×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio18.4×-15.1×

Where this comes from

Calculated from Roivant Sciences’s reported figures.

Based on the most recent quarter.

The official record: Roivant Sciences’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Roivant Sciences's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Roivant Sciences's cash ratio?
Roivant Sciences (ROIV) reported cash ratio of 5× in Q1 2026.
How has Roivant Sciences's cash ratio changed year-over-year?
Roivant Sciences's cash ratio increased by 702.5% year-over-year, from 0.6× to 5×.
What is the long-term trend for Roivant Sciences's cash ratio?
Over 4 years (2021 to 2025), Roivant Sciences's cash ratio has grown at a -35.9% compound annual growth rate (CAGR), from 43× to 7.2×.
What does cash ratio mean?
How much of its short-term bills the company could pay with cash on hand right now.
How do you interpret cash ratio?
A buffer against stress, but persistently high cash ratios can indicate under-deployed capital. Interpret alongside the company's capital-allocation strategy.
How does cash ratio compare across companies?
Varies widely by business model and treasury policy; best read against the company's own history.